Ellington Management Group’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,700	Closed	-$209K	–	447
2018 Q3	$209K	Buy	+4,700	New	+$209K	0.06%	432
2018 Q2	–	Sell	-17,000	Closed	-$1.23M	–	591
2018 Q1	$1.23M	Buy	+17,000	New	+$1.23M	0.09%	128